InvestorsHub Logo
icon url

hnbadger1

07/27/22 7:26 AM

#367711 RE: georgejjl #367710

Looks like Anavex’s competition is narrowing,
Amyloid drugs being called out.
Cassava is facing big problems.

Time for Anavex to shine!

Let’s go Dr Missling. Make it happen!
icon url

ExtremelyBullishZig

07/27/22 8:13 AM

#367721 RE: georgejjl #367710

Not yet...but that is because they haven't run trials that the FDA would consider.